http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114231498-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2303-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F3-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-3571 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F3-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L3-3571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate | 2021-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114231498-B |
| titleOfInvention | A multi-drug resistant mesophilic sphingosine bacteriophage and its application |
| abstract | The invention discloses a multi-drug resistant mesophilic sphingosine bacteriophage and its application. The bacteriophage is named Sphingobacterium thalpophilum phage in Latin and named as PW84. The bacteriophage PW84 is preserved in the China Center for Type Culture Collection (CCTCC). The date is September 9, 2021, and the deposit number is CCTCC NO: M 20211149; the phage has a strong specific lysis effect on Sphingosine mesophila, and can be obtained by co-cultivation of its host bacteria for mass propagation; the phage is in the environment It has strong survival adaptability, and the phage with a certain titer still maintains a certain activity under the conditions of 4≤pH≤12, 4≤T≤80℃; the phage of this scheme can be applied to natural environments such as sewage, farmland, soil, etc. It can effectively kill and prevent the proliferation and spread of multidrug-resistant Sphingosine mesophilic bacteria in indoor environments such as laboratories and farms. Compared with antibiotic therapy, it is safe, efficient and low-cost. The advantages. |
| priorityDate | 2021-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.